Health & Biotech
Health & Biotech
Osteopore delivers three straight quarters of growth in record financial performance
Health & Biotech
Creso Pharma’s acquisition target lands deal with leading US online health marketplace
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
Health & Biotech
Neurotech eyes Phase II/III trial and FDA approval after cannabis breakthrough on paediatric autism
Health & Biotech
ASX Health Stocks: Inoviq pockets another US patent, its second in a month
Health & Biotech
Nutritional Growth Solutions just signed a key distribution deal in US
Health & Biotech
Incannex receives key ethics approval to start Phase 1 clinical trial of multi-use anti-inflammatory drug
Health & Biotech
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
Health & Biotech
ASX Health Stocks: HeraMED up 17pc and Mesoblast 12pc after strong study results
Health & Biotech
Wellnex shares jump ~10% on OneLife Botanicals deal
Health & Biotech
ASX Health Stocks: Ansell commits to net zero by 2040, but says Scope 3 needs more work
Health & Biotech
Dr Boreham’s Crucible: Is serial shopper Trajan Group a buy?
Health & Biotech
Prescient first in class cancer drug PTX-100 granted Orphan Drug status by the US FDA
Health & Biotech
MGC Pharma’s shares spike more than 20pc on positive trial of ArtemiC Support into Long Covid
Health & Biotech
Weed Week: An Aussie medicinal cannabis farm for sale and crypto ATMs in weed dispensaries
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.